Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/1995
10/31/1995US5463062 Inhibitors of glucose-6-phosphatase system
10/31/1995US5462962 Tetrahydrobenz[c,d]indole serotonin agonists
10/31/1995US5462946 Metal-independent nitroxide or oxazolidine-1-oxyl forming compound in biologically acceptable carrier to protect biological material from oxidative stress
10/31/1995US5462933 Modified bile acid conjugates, and their use as pharmaceuticals
10/31/1995US5462924 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa
10/26/1995WO1995028480A1 Methods of use of uncoated gel particles
10/26/1995WO1995028426A2 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis
10/26/1995WO1995028419A1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines
10/26/1995WO1995028401A1 Tropane-2-aldoxine derivatives as neurotransmitter reuptake inhibitors
10/26/1995WO1995028399A1 A method of inducing cholecystokinin agonist activity using 1,4-benzodiazepine compounds
10/26/1995WO1995028391A1 Cck or gastrin modulating 1,5 benzodiazepines derivatives
10/26/1995WO1995028172A1 Human bone stimulating factor
10/26/1995WO1995028170A1 Icam-1/lfa-1 short-chain peptides and method of using same
10/26/1995WO1995028167A1 Methods of treating disease using sertoli cells and allografts or xenografts
10/26/1995WO1995028163A1 Enteral formulations for the treatment of inflammation and infection containing a saponin, possibly in combination with other compounds
10/26/1995WO1995028160A1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
10/26/1995CA2188287A1 Icam-1/lfa-1 short-chain peptides and method of using same
10/26/1995CA2188172A1 Human bone stimulating factor
10/26/1995CA2187642A1 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis
10/26/1995CA2187526A1 Methods of use of uncoated gel particles
10/26/1995CA2186900A1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines
10/26/1995CA2186872A1 Cck or gastrin modulating 1,5 benzodiazepines derivatives
10/26/1995CA2186738A1 Enteral formulations for the treatment of inflammation and infection containing a saponin, possibly in combination with other compounds
10/25/1995EP0678522A1 Insulin analogs
10/25/1995EP0678503A1 Delta-amino-gamma-hydroxy-omega-aryl alkanoic acid amides with enzyme especially renin inhibiting activities
10/25/1995EP0678087A1 Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors
10/25/1995EP0678086A1 Compounds having selectivity for retinoid x receptors
10/25/1995EP0678020A1 Compositions comprising cholesterol lowering agents and antioxidants
10/25/1995CN1110685A Nitrogen-containing spirocycles
10/24/1995US5461073 Septicemia suppressing substitution fluid preparation
10/24/1995US5461035 Short peptides with insulin activity
10/24/1995US5461031 Monomeric insulin analog formulations
10/24/1995US5460951 Bone-related carboxypeptidase-like protein and process for its production
10/24/1995US5460820 Methods for providing testosterone and optionally estrogen replacement therapy to women
10/24/1995CA1337420C (substituted aralkyl) heterocyclic compounds
10/24/1995CA1337415C Indole derivatives
10/21/1995CA2147429A1 Piperidine derivatives and anti-platelet agents containing the same
10/19/1995WO1995027793A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICErel-II)
10/19/1995WO1995027500A1 TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES
10/19/1995WO1995027499A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
10/19/1995WO1995027496A1 Vasoactive intestinal polypeptide
10/19/1995WO1995027495A2 Treatment of partial growth hormone insensitivity syndrome
10/19/1995WO1995027483A1 Carotenoid agent for inhibiting the conversion of epithelial cells to tumours
10/19/1995CA2187367A1 Carotenoid agent for inhibiting the conversion of epithelial cells to tumours
10/19/1995CA2187345A1 Treatment of autoimmune disease using oral tolerization and/or th2-enhancing cytokines
10/19/1995CA2187322A1 Vasoactive intestinal polypeptide
10/19/1995CA2185353A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
10/18/1995EP0677063A1 A NEW CLASS OF RPTPases: THEIR STRUCTURAL DOMAINS AND LIGANDS
10/18/1995EP0677062A1 Derivatized calcitonins
10/18/1995EP0677039A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
10/18/1995EP0676960A1 Cycloalkyl amine bis-aryl squalene synthase inhibitors
10/18/1995EP0676951A1 Use of vitamin d glycosides for the treatment or prevention of osteoporosis
10/18/1995EP0569393B1 Derivatives of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions for enteral and parenteral nutrition
10/18/1995CN1030077C Process for preparation of antihypercholesterolemic
10/17/1995US5459164 1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutylamine compounds are administered to improve glucose tolerance; diabetes
10/17/1995US5459135 Administer synergistic amounts of dedimethylaminotetracycline and indomethacin
10/17/1995US5459036 Extracellular signal-regulated kinase, sequences, and methods of production and use
10/17/1995CA2060789C Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
10/17/1995CA2001671C Aqueous elcatonin solution composition
10/17/1995CA1337351C Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
10/17/1995CA1337337C Acidic polycyclic ether antibiotic having anticoccidial and growth promotant activity
10/12/1995WO1995027202A1 Screening method using the rzr receptor family
10/12/1995WO1995027052A1 Human interleukin variants generated by alternative splicing
10/12/1995WO1995027044A1 ALPHAVIRUS cDNA VECTORS
10/12/1995WO1995026984A1 Process for producing composition containing bovine insulin-like growth factor 1
10/12/1995WO1995026973A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects
10/12/1995WO1995026963A1 Stable aqueous folinate solution
10/12/1995WO1995026957A1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists
10/12/1995CA2186854A1 Human interleukin variants generated by alternative splicing
10/12/1995CA2186636A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects
10/12/1995CA2184261A1 Alphavirus cdna vectors
10/12/1995CA2182700A1 Screening method using the rzr receptor family
10/12/1995CA2146701A1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use
10/11/1995EP0676414A1 Lipases immobilized in sol-gel processed hydrophobic materials
10/11/1995EP0676398A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use
10/11/1995EP0676205A1 Cerebral metabolism activator containing glucose ester derivative
10/11/1995EP0676203A1 Pharmaceutical compositions of antiglucocorticoid compounds for treating or preventing symptoms of spontaneous or narcotic-induced withdrawal
10/11/1995EP0676194A2 Cosmetic or dermatological compositions comprising an alpha-hydroxy acid, salicylic acid and a retinoid
10/11/1995EP0675902A1 Endothelin antagonists
10/11/1995EP0675883A1 Piperidine derivatives as calcium channel antagonists
10/11/1995EP0675735A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof
10/11/1995EP0675714A1 COMBINATION OF A CHOLESTEROL BIOSYNTHESIS INHIBITOR AND A $g(b)-LACTAM CHOLESTEROL ABSORPTION INHIBITOR
10/11/1995EP0457814B1 Increased protein production in animals
10/11/1995CN1109870A N-(3-aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphtalene-2-carboxamide derivative, preparation and application of same
10/11/1995CN1109751A Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof
10/11/1995CN1029974C Novel alpha-glucosidase inhibitors
10/11/1995CN1029963C Thiazine or oxazine derivatives and preparation thereof
10/11/1995CN1029935C Pharmaceutical preparation and process for same
10/10/1995US5457237 Used in treating cancer and-or atherosclerosis
10/10/1995US5457217 Treating bone disorders, osteoporosis
10/10/1995US5457205 Substituted thiazoles useful for treatment of diabetes
10/10/1995US5457129 Inhibition of nitric oxide production by retinoic acid
10/10/1995US5457109 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
10/10/1995US5457047 DNA Sequences coding for PTH variants, PTH variants, expression vector, bacterial host, use and therapeutic composition
10/10/1995US5456924 Method of treatment of HIV-seropositive individuals with dietary whey proteins
10/10/1995CA1337295C Dihydropyridine derivatives and their preparation and pharmaceutical formulation
10/09/1995CA2146600A1 Products with antiglucocorticoid activity used for preparing drugs intended for the prevention or the treatment of manifestations caused by a spontaneous or a precipitated withdrawal symptom due to narcotics or mixtures of narcotics; compositions containing the same
10/05/1995WO1995026360A1 Antagonists of endothelin receptors
10/05/1995WO1995026358A1 2,4-diphosphonoglutaric acid derivatives, methods of preparing such compounds and drugs containing them
10/05/1995WO1995026349A1 INDENO[1,2-e]PYRAZINE-4-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
1 ... 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 ... 1298